Human Respiratory Syncytial Virus vaccine (RSV vaccine)

The Respiratory Syncytial Virus (RSV) vaccine helps protect people, especially infants and older adults, from a common virus that causes lung infections like bronchiolitis and pneumonia. RSV spreads through coughs, sneezes, or close contact. The vaccine stimulates the immune system to recognize and fight RSV, reducing the risk or severity of illness. It is an important tool in preventing serious respiratory infections caused by RSV, especially in vulnerable populations. The vaccine's development has improved recent strategies for protecting at-risk groups from this widespread and potentially severe virus.